🇺🇸 FDA
Pipeline program

Platelet Rich Plasma

608.1/Dir/RSIA.SM/XII/2022

Phase 3 mab completed

Quick answer

Platelet Rich Plasma for Severe Oligoasthenoteratozoospermia is a Phase 3 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Severe Oligoasthenoteratozoospermia
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials